Your browser doesn't support javascript.
loading
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
van de Loosdrecht, Arjan A; Kern, Wolfgang; Porwit, Anna; Valent, Peter; Kordasti, Sharham; Cremers, Eline; Alhan, Canan; Duetz, Carolien; Dunlop, Alan; Hobo, Willemijn; Preijers, Frank; Wagner-Ballon, Orianne; Chapuis, Nicolas; Fontenay, Michaela; Bettelheim, Peter; Eidenschink-Brodersen, Lisa; Font, Patricia; Johansson, Ulrika; Loken, Michael R; Te Marvelde, Jeroen G; Matarraz, Sergio; Ogata, Kiyoyuki; Oelschlaegel, Uta; Orfao, Alberto; Psarra, Katherina; Subirá, Dolores; Wells, Denise A; Béné, Marie C; Della Porta, Matteo G; Burbury, Kate; Bellos, Frauke; van der Velden, Vincent H J; Westers, Theresia M; Saft, Leonie; Ireland, Robin.
Afiliação
  • van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Kern W; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Porwit A; Department of Clinical Sciences, Division of Oncology and Pathology, Faculty of Medicine, Lund University, Lund, Sweden.
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Kordasti S; Comprehensive Cancer Centre, King's College London, London, UK.
  • Cremers E; Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Alhan C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Duetz C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Dunlop A; Department of Haemato-Oncology, Royal Marsden Hospital, London, UK.
  • Hobo W; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Preijers F; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Wagner-Ballon O; Department of Hematology and Immunology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, Créteil, France.
  • Chapuis N; Université Paris-Est Créteil, Inserm U955, Créteil, France.
  • Fontenay M; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Centre-Université de Paris, Paris, France.
  • Bettelheim P; Institut Cochin, Université de Paris, INSERM U1016, CNRS UMR 8104, Paris, France.
  • Eidenschink-Brodersen L; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Centre-Université de Paris, Paris, France.
  • Font P; Institut Cochin, Université de Paris, INSERM U1016, CNRS UMR 8104, Paris, France.
  • Johansson U; Department of Hematology, Ordensklinikum Linz, Elisabethinen, Linz, Austria.
  • Loken MR; HematoLogics, Inc., Seattle, Washington, USA.
  • Te Marvelde JG; Department of Hematology, Hospital General Universitario Gregorio Marañon - IiSGM, Madrid, Spain.
  • Matarraz S; Laboratory Medicine, SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Ogata K; HematoLogics, Inc., Seattle, Washington, USA.
  • Oelschlaegel U; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Orfao A; Cancer Research Center (CIC/IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, Salamanca, Spain.
  • Psarra K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan.
  • Subirá D; Department of Internal Medicine, University Hospital Carl-Gustav-Carus TU Dresden, Dresden, Germany.
  • Wells DA; Cancer Research Center (CIC/IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, Salamanca, Spain.
  • Béné MC; Department of Immunology - Histocompatibility, Evangelismos Hospital, Athens, Greece.
  • Della Porta MG; Department of Hematology, Flow Cytometry Unit, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Burbury K; HematoLogics, Inc., Seattle, Washington, USA.
  • Bellos F; Hematology Biology, Nantes University Hospital and CRCINA, Nantes, France.
  • van der Velden VHJ; IRCCS Humanitas Research Hospital, Milan, Italy.
  • Westers TM; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Saft L; Department of Haematology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Australia.
  • Ireland R; MLL Munich Leukemia Laboratory, Munich, Germany.
Cytometry B Clin Cytom ; 104(1): 77-86, 2023 01.
Article em En | MEDLINE | ID: mdl-34897979

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos